nialamide has been researched along with Alloxan Diabetes in 5 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1 In nialamide-treated mice, L-5-hydroxytryptophan produced a dose-dependent hypoglycaemic response which was independent of whether the animals had been fed or fasted." | 1.25 | The hypoglycaemic effect of 5-hydroxytryptophan. ( Furman, BL, 1974) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buschiazzo, HO | 3 |
| Hernández, RE | 1 |
| RodrÃguez, RR | 2 |
| Furman, BL | 1 |
| Lundquist, I | 1 |
| Ekholm, R | 1 |
| Ericson, LE | 1 |
| Canestro de Vasini, E | 1 |
| Bosch, R | 1 |
5 other studies available for nialamide and Alloxan Diabetes
| Article | Year |
|---|---|
Preventive action of tranylcypromine on alloxan diabetes in rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Injections, Intraperitoneal; Nialamid | 1967 |
The hypoglycaemic effect of 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Adipose Tissue; Animals; Blood Glucose; Cyproheptadine; Diabetes Mellitus, Expe | 1974 |
Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Glucose; Glybu | 1971 |
Chemical interaction between monoamineoxidase inhibitors and alloxan.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Drug Stability; Half-Life; Monoamine Oxidase Inhi | 1971 |
Preventive action of the monoaminooxidase inhibitor, nialamide, on experimental diabetes in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Monoamine Oxidase Inhibitors; Nialamide; Pancreatectomy; R | 1966 |